TARGETED RADIOPHARMACEUTICALS AND IMAGING DEVELOPMENT CHALLENGES AND OPPORTUNITIES (HB 2025). Este artículo no está disponible.
Idioma: inglés
Editorial: RSC PUBLISHING (NP), 2025
- Tapa dura
- Nuevo
Librería: UK BOOKS STORE, London, London, Reino UnidoUK BOOKS STORE
Vendedor de IberLibro desde 11 de marzo de 2024
Condición: Nuevo
EUR 363,79
Descripción del artículo del vendedor
Brand New ! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
N° de ref. del artículo Cvs 9781837673278
- Título
- TARGETED RADIOPHARMACEUTICALS AND IMAGING DEVELOPMENT CHALLENGES AND OPPORTUNITIES (HB 2025)
- Autor
- SRIVASTAVA V
- Editorial
- RSC PUBLISHING (NP)
- Año de publicación
- 2025
- Estado
- New
- Encuadernación
- Encuadernación de tapa dura
- Idioma
- inglés
- ISBN 10
- 1837673276
- ISBN 13
- 9781837673278
- Edición
- Edición Internacional
Targeted radiopharmaceutical therapy (RPT) is emerging as an innovative approach for treating a wide range of cancers.
Almost all radionuclides used in RPT emit photons that can be imaged, enabling non-invasive visualization of the therapeutic agent's biodistribution. The remarkable potential of radiopharmaceutical therapy is now being recognized with recent FDA approval of several RPT drugs and a significant number of drug candidates in clinical development.
This book offers a comprehensive perspective on the different technologies and addresses the critical challenges in developing and commercializing radiopharmaceuticals. It covers various topics, from clinical applications to specific radiopharmaceutical biodistribution, dosimetry, and novel targets in oncology. The chapters provide a cohesive picture of the advances in SPECT/CT and PET/CT imaging, clinical trends in targeted therapies utilizing radioisotopes for cancer imaging, and clinical applications of radiotracers within oncology areas. It also delves into the manufacturing technologies and regulatory and supply logistics required to support the development of the next wave of targeted alpha therapies.
This resource is ideal for postgraduates and researchers in drug discovery and development in radionuclide therapy and imaging in cancer, as well as medical professionals engaged in nuclear medicine and radiology.
“Sinopsis” puede pertenecer a otra edición de este título.